IMAS
UTHR icon

ID Management A/S’s United Therapeutics UTHR Stock Holding History

ID Management A/S’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,200
Closed -$157K – 325
2015
Q3 		$157K Buy
+1,200
New +$192K 0.07% 186
2015
Q1 		$207K Hold
1,200
– – 0.1% 153
2014
Q4 		$155K Buy
+1,200
New +$155K 0.07% 193

Other funds holding UTHR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

ID Management A/S's UTHR Position: Q4 2015 in Review

ID Management A/S sold out of United Therapeutics (UTHR) in Q4 2015, closing a stake of 1,200 shares — an estimated $157K sold.

ID Management A/S first reported a position in UTHR in Q4 2014 and held it in 3 quarters. The position peaked at $207K in Q1 2015. 386 funds tracked by Wall St. Rank hold UTHR as of Q4 2015.

  • ID Management A/S reported no remaining United Therapeutics position as of Q4 2015 after selling out during the quarter.
  • ID Management A/S sold 1,200 United Therapeutics shares in Q4 2015, an estimated $157K.
  • ID Management A/S first reported a position in United Therapeutics in Q4 2014 and held it in 3 quarters.
  • ID Management A/S's United Therapeutics position peaked at $207K in Q1 2015.
  • 386 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2015.

Based on ID Management A/S's 13F filing for Q4 2015, filed 13 Jan 2016.